<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94092">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01915355</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 13D.230</org_study_id>
    <nct_id>NCT01915355</nct_id>
  </id_info>
  <brief_title>Pulsed Dye Laser Treatment of Onychomycosis</brief_title>
  <official_title>Pulsed Dye Laser Treatment of Onychomycosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to investigate the use of the Candela V-beam Pulsed Dye
      Laser for the treatment of onychomycosis, or nail fungus.

      Hypothesis: Complete nail clearance will occur in approximately half of patients after 3
      laser treatments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      10 patients will participate nationally.  The investigators hope to enroll all 10 patients
      at Jefferson. Involvement in the study will last about 8-12 weeks for the subject.  The
      entire study will take about 12 months to complete.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Total Nail Clearance</measure>
    <time_frame>approximately 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>After 3 laser treatments, the subject should experience clinical clearance.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Onychomycosis</condition>
  <arm_group>
    <arm_group_label>Pulsed Dye Laser for fungus treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The purpose of this research is to investigate the use of the Candela V-beam Pulsed Dye Laser for the treatment of onychomycosis, a common nail fungus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed Dye Laser for the treatment of nail fungus</intervention_name>
    <description>The purpose of this research is to investigate the use of the Candela V-beam Pulsed Dye Laser for the treatment of onychomycosis, a common nail fungus.</description>
    <arm_group_label>Pulsed Dye Laser for fungus treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18-65 years old

          -  Diagnosis of onychomycosis based on positive fungal culture for dermatophyte and
             positive PAS from toenail clipping

        Exclusion Criteria:

          -  HIV/immunosuppression

          -  Candidal toenail infection

          -  Prior PO antifungal therapy within last 6 months

          -  Personal history of psoriasis, lichen planus, or significant photosensitivity
             disorder

          -  Any serious generalized medical condition
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nazanin Saedi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jefferson Dermatology Associates</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jefferson Dermatology</last_name>
    <phone>215-955-6680</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Jefferson Dermatology Associates</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferson Dermatology</last_name>
      <phone>215-955-6680</phone>
    </contact>
    <investigator>
      <last_name>Joya Sahu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nazanin Saedi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 4, 2014</lastchanged_date>
  <firstreceived_date>July 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>onychomycosis</keyword>
  <keyword>nail</keyword>
  <keyword>fungus</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Onychomycosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
